Luo et al. detected the peripheral blood mononuclear cells of breast cancer patients and the culture supernatant to detect the level of IL-4 and found that the level of IL-4 in breast cancer patients is higher than that in the normal control group, which has a markedly different significance (P < 0.05). This evidence concerns the gene IL4 and breast cancer.